CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 458 enrolled
Drug / intervention
Duloxetine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01855919
NCT01855919Phase 3Completed
CompareCT.gov

Effect of Duloxetine 60 mg Versus Placebo in Patients With Chronic Low Back Pain in Japan

Eli Lilly and Company·interventional·Posted May 17, 2013·Updated Jul 23, 2015

In Brief

A Phase 3 clinical trial evaluating Duloxetine and Placebo for Back Pain Lower Back Chronic. Completed, enrolled 458 participants across 1 site.

Detailed Summary

The purpose of the study is to assess the efficacy and safety of duloxetine in participants with Chronic Low Back Pain (CLBP).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBack Pain Lower Back Chronic
CountriesJapan
CollaboratorsShionogi

Timeline

Phase 3CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMay 17, 2013
Enrollment StartMay 1, 2013
Primary CompletionJul 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 13.1 years ago

Interventions

Duloxetinedrug

Administered orally

Placebodrug

Administered orally